Close Menu

NEW YORK – The legal battle over the ownership rights to foundational patents for CRISPR-Cas9 technology took a nasty turn this week after the University of California and its co-plaintiffs in the case accused the Broad Institute's Feng Zhang and his collaborator Neville Sanjana of making "untrue" and "materially false" declarations in the Broad's original patent applications.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.

The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.